NewAmsterdam Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAMS and other ETFs, options, and stocks.About NAMS
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol.
CEOMichael H. Davidson
CEOMichael H. Davidson
Employees68
Employees68
HeadquartersNaarden, Noord-Holland
HeadquartersNaarden, Noord-Holland
Founded2022
Founded2022
Employees68
Employees68
NAMS Key Statistics
Market cap4.17B
Market cap4.17B
Price-Earnings ratio-23.64
Price-Earnings ratio-23.64
Dividend yield—
Dividend yield—
Average volume855.40K
Average volume855.40K
High today$38.98
High today$38.98
Low today$36.51
Low today$36.51
Open price$38.38
Open price$38.38
Volume632.74K
Volume632.74K
52 Week high$41.47
52 Week high$41.47
52 Week low$14.06
52 Week low$14.06
Stock Snapshot
The current NewAmsterdam Pharma(NAMS) stock price is $37.05, with a market capitalization of 4.17B. The stock trades at a price-to-earnings (P/E) ratio of -23.64.
On 2025-11-06, NewAmsterdam Pharma(NAMS) stock traded between a low of $36.51 and a high of $38.98. Shares are currently priced at $37.05, which is +1.5% above the low and -4.9% below the high.
NewAmsterdam Pharma(NAMS) shares are trading with a volume of 632.74K, against a daily average of 855.4K.
In the last year, NewAmsterdam Pharma(NAMS) shares hit a 52-week high of $41.47 and a 52-week low of $14.06.
In the last year, NewAmsterdam Pharma(NAMS) shares hit a 52-week high of $41.47 and a 52-week low of $14.06.
Analyst ratings
87%
of 15 ratingsBuy
86.7%
Hold
13.3%
Sell
0%
People also own
Based on the portfolios of people who own NAMS. This list is generated using Robinhood data, and it’s not a recommendation.